Search Results
Dec 10, 2025, 08:17 ET SPARE CAPACITY PERSISTS GLOBALLY, WHILE NORTH AMERICA REPORTS A STEEPER PULLBACK IN MANUFACTURING DEMAND, SIGNALLING WEAK CONDITIONS HEADING INTO 2026: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
orts-a-steeper-pullback-in-manufacturing-demand-signalling-weak-conditions-heading-into-2026-gep-global-supply-chain-volatility-index-302637143.htmlSOURCE GEP
More news about: GEP
Dec 10, 2025, 08:07 ET J.S. Held and Experts Recognized as Industry Leaders in 2025
LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.Media ContactKristi L. Stathis, J.S. Held, +1 786 833 4864, [email protected], JSHeld.com
More news about: J.S. Held
Dec 10, 2025, 08:07 ET J.S. Held and Experts Recognized as Industry Leaders in 2025
LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.Media ContactKristi L. Stathis, J.S. Held, +1 786 833 4864, [email protected], JSHeld.comLogo
More news about: J.S. Held
Dec 10, 2025, 08:05 ET LEPAS L8 エクスクイジット・スペース: 感情主導のライフスタイルのための、心を鎮めるエモーショナル・サンクチュアリ
思い立ったキャンプでも、LEPAS L8 のエクスクイジット・スペースは理想的なアウトドアコンパニオンへと早変わりします。広々としたトランクとフラットに倒せるシートにより、ゆったりとしたラウンジエリアを簡単に作り出せます。パノラマルーフが、境界のないクリアな視界を広げます。テントは不要—見上げるだけで、ロマンチックな星空を楽しめます。リアのトレーテーブルを展開すれば、あなた専用の"モバイルコーヒーコーナー"がその場で生まれます。このエクスクイジット・スペースでは、エレガントなライフスタイルが美しく、そして実感を伴って形になります。LEPAS L8 のエクスクイジット・スペースは、
More news about: LEPAS
Dec 10, 2025, 08:00 ET Veritiv Expands Its TempSafe® Portfolio With the Industry's First Curbside-Recyclable Pallet Shipper for Biopharmaceutical Cold Chain
eliminate the disposal costs tied to traditional EPS and PUR pallet systems.Delivering more than five days of validated thermal protection, a 558–596L payload, and capacity for more than 300 pounds of dry ice, TempSafe® PalletShield™ integrates seamlessly into standard pallet workflows.
More news about: Veritiv Operating Company
Dec 10, 2025, 07:45 ET Publication in Nature's Scientific Reports Reinforces Spiderwort Biotechnologies' Cellulose-Based Platform with New Findings on Neural Repair and Motor Recovery
encouraging validation for the potential of cellulose-based biomaterials in regenerative medicine applications. The publication, titled Poly-L-Ornithine coated plant scaffolds support motor recovery in rats after traumatic spinal cord injury, counts Spiderwort Biotechnologies' Chief Executive
More news about: Spiderwort Biotechnologies Inc.
Dec 10, 2025, 06:45 ET "Supports Steady Energy, Focus, and Metabolic Balance" - Gundry MD MCT Wellness Wins A 2025 Nourish Award for Best Supplement
76 years old and MCT Wellness is part of my morning ritual. My energy level is amazing and I have such mental clarity. Thank you Dr. Gundry." - Betty L."Since late May I have used this product every day. I have lost 41 pounds…If only I had found Dr Gundry sooner. He is amazing and explains the
More news about: Gundry MD
Dec 10, 2025, 06:03 ET NiTEO Products, a Portfolio Company of Highlander Partners, Acquires Faultless Brands
categories. We are looking forward to building upon the 138-year-old heritage of the portfolio and continuing to take these brands to new heights."Jeff L. Hull, Highlander President and CEO, said, "This acquisition reconfirms our strategy of executing strategic add-on acquisitions that enhance and expand
More news about: Highlander Partners, L.P.
Dec 10, 2025, 06:00 ET CFOs take ownership as cloud becomes a financial risk factor
The Cost of Compute: What 100 CFOs Reveal About Cloud Infrastructure's Impact on the P&L' and revealed a sector feeling the financial weight of cloud dependence:Cloud spend now averages 10% of revenueNearly
More news about: Cloud Capital Technologies Holdings
Dec 10, 2025, 04:00 ET NTC, SOSTENUTA DA WISE EQUITY, COMPLETA L'ACQUISIZIONE DEL BUSINESS OFTALMICO DI PHARMATHEN
europeo dell'oftalmologia.L'operazione consente a NTC di raggiungere circa 100 milioni di euro di ricavi, di cui oltre l'80% in oftalmologia, e di espandere ulteriormente la propria presenza internazionale includendo anche il mercato statunitense.MILANO,
More news about: NTC Srl
Dec 10, 2025, 04:00 ET NTC, con el respaldo de Wise Equity, completa la adquisición del negocio de oftalmología de Pharmathen
totalmente invertidos en ocho empresas, con siete todavía en cartera después de la venta de Cantiere del Pardo; • Wisequity VI l lanzado en mayo de 2023 con un compromiso total de 400 millones de euros, desplegados parcialmente en cuatro inversiones. Foto -
More news about: NTC Srl
Dec 10, 2025, 00:39 ET LEPAS L8精緻空間：情緒派的鬆弛感治癒小宇宙
LEPAS L8的精緻空間，更是屬於自己的情緒自留地。躺在雲感舒躺座椅上，將靠背調節至最放鬆的角度，選擇適合自己的按摩模式，肩頸的疲憊便在不知不覺中消散；極速熱管理系統精準維持適宜溫度，主動香氛系統跟隨心情在提神與舒緩模式間轉換，劇院級靜謐座艙全方位營造鬆弛氛圍，無論車外如何喧囂，車內始終保持著寧靜和清新——靜靜放空思緒，盡情享受這份屬於自己的鬆弛感。LEPAS L8的精緻空間不只是物理載體，更像一個懂你的好夥伴，像你的情感容器。無論是午休時透過天窗看雲卷雲舒，還是獨享座艙沉浸觀影時刻，總能為你提供舒適的「情緒棲息地」，做你的優雅生活「避風港」。
More news about: LEPAS
Dec 10, 2025, 00:36 ET LEPAS L8 Exquisite Space: A Calming Emotional Sanctuary for the Emotion-Led Lifestyle
cities, people increasingly seek relaxation, emotional balance, and a space that truly belongs to themselves. LEPAS shapes the LEPAS L8's Exquisite Space into a mobile emotional sanctuary—turning every departure and pause into a moment of Elegant Life and effortless comfort.
More news about: LEPAS
Dec 10, 2025, 00:14 ET LEPAS L8 Exquisite Space: A Calming Emotional Sanctuary for the Emotion-Led Lifestyle
cities, people increasingly seek relaxation, emotional balance, and a space that truly belongs to themselves. LEPAS shapes the LEPAS L8's Exquisite Space into a mobile emotional sanctuary—turning every departure and pause into a moment of Elegant Life and effortless comfort.
More news about: LEPAS
Dec 09, 2025, 23:25 ET Lancement des gammes à énergie nouvelle AION et HYPTEC de GAC au salon de l'automobile de Riyad : un nouveau chapitre sur le marché du Moyen-Orient
la forte détermination de GAC à renforcer sa présence en Arabie saoudite et marque une accélération du déploiement de sa stratégie au Moyen-Orient, l'« Action au Moyen-Orient ».
More news about: GAC
Dec 09, 2025, 23:19 ET Il Gruppo Menarini presenta i dati di fase 2 sulla combinazione di elacestrant (ORSERDU®) in pazienti affetti da carcinoma mammario metastatico (mBC) ER+, HER2- al Simposio sul cancro al seno di San Antonio del 2025
della presentazione: Venerdì 12 dicembre 2025, 12:30 – 14:00Sala: Henry B. Convention CenterAutore presentatore: Sara L. SammonsTitolo della presentazione: Hormonal receptor (HR)-positive HER2 negative breast cancer patients treated with preoperative Elacestrant
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 17:28 ET Xcaliber International General Counsel Eric Estes Named a 2026 Legends in Law Honoree
Miller Friel, PLLC; Bernard Nash, State Attorneys General Practice Co-Chair, Cozen O'Connor; Brian D. Burton, Senior Attorney, Alston & Bird; Hubert L. Allen, Executive Vice President, General Counsel and Secretary, Abbott; Craig T. Beazer, Executive Vice President and General Counsel, Lincoln Financial;
More news about: Xcaliber International
Dec 09, 2025, 17:04 ET Shipt Partners with the City of Birmingham to Distribute Holiday Groceries to 1,000 Families Across Birmingham
burden. "Birmingham is a city known for its heart, and that's even more apparent during this season of giving," said Birmingham Mayor Randall L. Woodfin. "We're so proud to partner with Shipt to support families who need help the most this holiday season, and we're equally grateful to every resident
More news about: Shipt
Dec 09, 2025, 16:15 ET ASHFORD HOSPITALITY TRUST ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES
alternatives to bridge that gap."In conjunction with forming the Special Committee, the Company has also terminated the current offering of its Series L and M Non-Traded Preferred Stock and suspended redemptions for all of its outstanding non-traded preferred stock.Ashford Hospitality Trust is a
More news about: Ashford Hospitality Trust, Inc.
Dec 09, 2025, 16:05 ET Supermicro Expands NVIDIA Blackwell Portfolio with New 4U and 2-OU (OCP) Liquid-Cooled NVIDIA HGX B300 Solutions Ready for High-Volume Shipment
and eliminate chilled water and compressors in data centers. Supermicro DCBBS delivers the new systems as fully validated, tested racks ready as L11 and L12 solutions before shipment, accelerating time-to-online for hyperscale, enterprise, and federal customers.These new systems expand Supermicro's
More news about: Super Micro Computer, Inc.
Dec 09, 2025, 16:05 ET Supermicro Expands NVIDIA Blackwell Portfolio with New 4U and 2-OU (OCP) Liquid-Cooled NVIDIA HGX B300 Solutions Ready for High-Volume Shipment
and eliminate chilled water and compressors in data centers. Supermicro DCBBS delivers the new systems as fully validated, tested racks ready as L11 and L12 solutions before shipment, accelerating time-to-online for hyperscale, enterprise, and federal customers.These new systems expand Supermicro's
More news about: Super Micro Computer, Inc.
Dec 09, 2025, 16:00 ET Cirius Therapeutics to Highlight Cardiometabolic Benefits of CIR-0602K at Global Cardiovascular Clinical Trialists (CVCT) Forum 2025
InflammationReduced high-sensitivity C-reactive protein (hsCRP) in participants with hsCRP above 3 mg/L at baseline by approximately 40%; person with hsCRP >3 mg/L are at high risk for future cardiovascular events. Lipid Profile and other
More news about: Cirius Therapeutics
Dec 09, 2025, 14:54 ET ADI Foundation anuncia el lanzamiento de la red principal de ADI Chain y el token de utilidad ADI
ADI Chain es la primera blockchain L2 de nivel institucional en la región MENA, con la tecnología y la solidez financiera necesarias para impulsar su adopción a gran escala. Su arquitectura modular, compatible con cadenas L3 opcionales, permite a instituciones de todo el mundo lanzar
More news about: ADI Foundation
Dec 09, 2025, 14:24 ET Menarini Group 於 2025 年聖安東尼奧乳癌研討會公佈 Elacestrant (ORSERDU®) 針對 ER+、HER2- 轉移性乳癌 (mBC) 患者的第 2 期聯合治療數據
轉移性乳癌患者。摘要編號：2119發表日期及時間：2025 年 12 月 12 日（星期五），下午 12:30 – 2:00地點： Henry B. Convention Center發表演講者：Sara L. Sammons簡報題目：術前接受 Elacestrant 及 PULSAR 自適應放射治療的荷爾蒙受體 (HR) 陽性 HER2 陰性乳癌患者：一項第 II 期研究 (HELP 試驗) 摘要編號：1071發表日期及時間：2025
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 13:09 ET Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
development in oncology, announced that they will present their Phase 1/2 study results of spevatamig (PT886) in combination with chemotherapy in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
More news about: Phanes Therapeutics, Inc.